Nasdaq Fertility Firm Newgenivf Sold 146,432 XRP for a $10,849 Profit
Covered by 1 source · 1 article
SEC filing: Nasdaq-listed Newgenivf bought and sold 146,432 XRP in 2025 for a $10,849 gain; its SOL stake now carries a $1.58M unrealized loss.
Covered by